Legend Biotech Corporation

Historical 13F Holders

Symbol
LEGN
CUSIP
52490G102
All holders as of
Q2 2026
Type
Equity
Class
SPONSORED ADS
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 52490G102 since 12/18/2024, newest first.

Filer % of Class Filed
FMR LLC 13G/A Amendment 9
15.0% 8/6/2026
Event 6/30/2026
FMR LLC 13G/A Amendment 8
13.1% 2/5/2026
Event 12/31/2025
FMR LLC 13G/A Amendment 7
15.0% 11/5/2025
Event 9/30/2025
FMR LLC 13G/A Amendment 6
13.9% 8/6/2025
Event 6/30/2025
FMR LLC 13G/A Amendment 5
10.9% 6/6/2025
Event 5/30/2025
Price T Rowe Associates Inc /MD/ 13G/A Amendment 2 3.7% 2/14/2025
Event 12/31/2024
FMR LLC 13G/A Amendment 4
7.3% 2/12/2025
Event 12/31/2024

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 15 143 k $2.83 M
2026 Q2 232 105 M $3.04 B
2026 Q1 211 96.1 M $1.74 B
2025 Q4 222 87.9 M $1.91 B
2025 Q3 219 84.0 M $2.74 B
2025 Q2 233 84.7 M $3.00 B
2025 Q1 228 86.6 M $2.91 B
2024 Q4 235 99.3 M $3.23 B
2024 Q3 227 91.6 M $4.46 B
2024 Q2 199 92.3 M $4.09 B
2024 Q1 222 87.7 M $4.92 B
2023 Q4 237 87.8 M $5.28 B
2023 Q3 223 86.0 M $5.78 B
2023 Q2 209 84.9 M $5.85 B
2023 Q1 175 68.1 M $3.28 B
2022 Q4 187 65.2 M $3.24 B
2022 Q3 176 65.7 M $2.68 B
2022 Q2 165 52.7 M $2.90 B
2022 Q1 154 51.5 M $1.88 B
2021 Q4 151 50.4 M $2.35 B
2021 Q3 95 39.0 M $1.97 B
2021 Q2 97 28.4 M $1.16 B
2021 Q1 77 26.4 M $767 M
2020 Q4 64 28.2 M $800 M
2020 Q3 52 24.5 M $755 M
2020 Q2 78 24.6 M $1.04 B